W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
New stent aims to relieve painful leg vein blockages
Disease control Recruiting nowThis study is testing a new medical device called the GORE VIAFORT stent to treat people with painful blockages in their major leg veins. The stent is placed to prop open the blocked vein and improve blood flow. Researchers will follow 165 participants for 5 years to see if the s…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New mesh aims to strengthen breast reconstruction after cancer surgery
Disease control Recruiting nowThis study is testing a new surgical mesh designed to support breast reconstruction after mastectomy. It will compare the safety and success of reconstruction using this new mesh against standard surgery without it. The goal is to see if the mesh helps reduce complications and im…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for dialysis patients: testing a Longer-Lasting lifeline
Disease control Recruiting nowThis study is testing a new type of artificial blood vessel, called the InnAVasc graft, for people with kidney failure who need dialysis. The goal is to see if this graft is safe and stays open long enough to be a reliable access point for dialysis treatments. Researchers will fo…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Artificial cornea implant offers new hope for cloudy vision
Disease control Recruiting nowThis early study is testing a new artificial cornea device for people with cloudy corneas who are candidates for a corneal transplant. The goal is to see if the implant is safe and can stay in place while improving vision. About 10 participants will be followed for at least one y…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Life-Saving aortic stent under close watch in japan
Disease control Recruiting nowThis study is monitoring the safety and performance of a specialized stent graft device after it has been approved for use in Japan. The device is used to treat dangerous conditions in the body's main chest artery, like aneurysms and tears, while preserving blood flow to a key ar…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New device offers lifeline for patients too sick for open heart surgery
Disease control Recruiting nowThis study is testing a new stent graft device to treat a life-threatening tear in the body's main artery, called a Type A aortic dissection. It is for patients who are considered too high-risk for traditional open-chest surgery. The goal is to see if this less invasive procedure…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors track new Stent's performance in real patients
Disease control Recruiting nowThis study is collecting real-world data on a specific stent graft device used to treat blocked arteries in the pelvis and abdomen (aortoiliac occlusive disease). It aims to see how safe and effective the device is one year after patients have had the procedure. The study is look…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Heart plug tested to stop repeat strokes
Disease control Recruiting nowThis study is testing a small implant that closes a small hole in the heart (called a PFO) to see if it safely prevents people from having another stroke. It will follow about 636 adults in the US who have had a recent stroke and have this specific heart condition. The main goal …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New aortic stent under Real-World watch
Disease control Recruiting nowThis study is monitoring the safety and performance of an already-approved stent graft device used to treat dangerous aortic aneurysms. It will follow 100 patients who receive the device in real-world medical practice to track complications, device success, and patient outcomes o…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
10-Year watch on aortic stents: tracking safety and durability
Disease control Recruiting nowThis study follows 2,000 patients for 10 years after they receive a Gore EXCLUDER stent to treat an abdominal aortic aneurysm (AAA). The goal is to collect real-world data on how well these stents perform over the long term, tracking safety, durability, and potential complication…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Tracking a new hernia mesh: does it hold up?
Knowledge-focused Recruiting nowThis study aims to collect real-world information on how well a specific surgical mesh (GORE ENFORM) works for repairing hernias. It will follow about 245 patients who have already received or will receive the mesh to see if the hernia comes back and to monitor for any complicati…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Massive 10-Year study tracks aortic stent safety
Knowledge-focused Recruiting nowThis study is collecting long-term data on a specific medical device—a stent graft—used to treat serious aortic conditions like aneurysms and dissections. It will follow 1,500 patients for up to ten years after their procedure to see how well the stent performs and what complicat…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC